SCOR to develop life insurance product concepts with CancerCARE
SCOR Life & Health in the US and INTERLINK Care Management, Inc. (CancerCARE) are announcing a program to develop a concierge-style CancerCARE program for life insurance policyholders.
Life & health insurance clients will have access to a customized product concept that is tailored to the life insurance market and “has been proven to be effective at extending and saving lives.”
CancerCARE is a cancer management programs used by large employers, captives, and TPAs as an embedded service.
The collaboration brings together the risk management expertise of SCOR and the accumulated knowledge of CancerCARE in emerging technologies and treatments, clinical trials, Center of Excellence access, pre-guideline care, NCCN Guideline care, and gene and cellular therapy to ensure the best cancer outcomes for life insurance policyholders.
“The partnership with CancerCARE is an important step for the life & health insurance industry to begin addressing cancer from a holistic perspective. Cancer treatments and new opportunities for cures are emerging almost daily, and we believe that CancerCARE can help save lives by providing policyholders with education, encouragement, and assistance in accessing treatment options that can positively impact their longevity.” – Richard De Sousa, EVP, SCOR U.S. Markets, Growth and Development.
“A cancer diagnosis that was once considered terminal may now be cureable, but access to these cures may require an experienced cancer team to help guide the patient through their cancer journey. The partnership with SCOR will help us expand the the reach of CancerCARE to more people and help them to better navigate the healthcare system.” – John Van Dyke, CEO of INTERLINK COE Networks & Programs and CancerCARE.
The companies have executed a Memorandum of Understanding outlining the terms for the design and implementation to occur in 2024.